AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines.
| Revenue (Most Recent Fiscal Year) | $303.91M |
| Net Income (Most Recent Fiscal Year) | $-184.35M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.59 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.42 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 2.59 |
| Pre-Tax Margin (Trailing 12 Months) | -14.85% |
| Net Margin (Trailing 12 Months) | -14.61% |
| Return on Equity (Trailing 12 Months) | -3.73% |
| Return on Assets (Trailing 12 Months) | -2.43% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.21 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.40 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 2.03 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.13 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.03 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.38 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.01 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 40.61M |
| Free Float | 38.41M |
| Market Capitalization | $451.55M |
| Average Volume (Last 20 Days) | 0.57M |
| Beta (Past 60 Months) | 0.62 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 5.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 89.43% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |